ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Evolution of SPK Transplant in Type I and Type II Diabetics with End Stage Renal Disease: The 20 Year Experience, The

J. Light, M. Tucker, M. Orquiza

Surgery, Washington Hospital Center, Washington, DC

Meeting: 2013 American Transplant Congress

Abstract number: C1384

Introduction: There continues to be much debate whether Type II diabetics can benefit from a SPK. We are reporting our 20 years experience in patients with end stage renal disease and diabetes mellitus who received a SPK transplant.

Methods: 173 Patients with end stage renal disease secondary to diabetes mellitus received a SPK transplant between 1989 and 2008, and were stratified by diabetes type.

Results: Refer to table I for patient characteristics. Type II diabetics had better graft survival than Type I diabetics, p=0.032; while Type I patients, had better patient survival than Type II patients (p=0.045).

Clinical Characteristics and Patient Demographics of SPK Transplant Recipients Stratified Diabetes Type (N=173)
  Type I (N=115) Type II (N=58) P-Value
DM Age of Onset 15.14 (±7.58) 24.2 (±10.54) P<0.0001
Age of Transplant 38.5 (±7.96) 42.8 (±8.40) P=0.0012
Mean C-Peptide 0.33 (±0.2) 5.34 (±3.66) P<0.0001
Pre Transplant BMI 23.1 (±3.4) 26.09 (±4.4) P<0.0001
Post Transplant BMI 24.7 (±4.7) 29.7 (±6.3) P<0.0001
Years Maintained on Insulin 22.5 (±7.16 19.19 (±7.08) P=0.012
Recipient's Race 41.7% African American 68.9% African American P=0.007
Graft Survival 65.5% 58.6% P=0.006
Pt. Survival 83.4% 75.8% P=0.228
Experienced Rejection 43.5% 41.8% P=0.793

Conclusion: Previous data had demonstrated that there were no differences at 5, 10, and 15 years post transplant. However, there appears to some differences at the 20 year follow-up. Type II patients had better graft survival, while Type I patients had better patient survival, which may be an indication at the age when patients were transplanted. Future studies should be conducted to follow long term follow-up and ascertain if those noted differences were true and not secondary to intrinsic population variables.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Light J, Tucker M, Orquiza M. Evolution of SPK Transplant in Type I and Type II Diabetics with End Stage Renal Disease: The 20 Year Experience, The [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/evolution-of-spk-transplant-in-type-i-and-type-ii-diabetics-with-end-stage-renal-disease-the-20-year-experience-the/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences